Alabama Collateral License Agreement between GeneLink, Inc. and The University of North Texas Health Science Center

• Category: Corporations - Public - Licenses
• State: Multi-State
• Control #: US-EG-9161
• Format: Word; Rich Text

Description

Collateral License Agreement between GeneLink, Inc. and The University of North Texas Health Science Center at Forth Worth dated July 1, 1996. 2 pages The Alabama Collateral License Agreement between Gentling, Inc. and The University of North Texas Health Science Center is a comprehensive legal agreement outlining the terms and conditions governing the use and licensing of intellectual property rights associated with a specific technology or invention. Keyword: Alabama Collateral License Agreement This agreement serves as a binding contract between Gentling, Inc., a cutting-edge biotechnology company, and The University of North Texas Health Science Center, a renowned academic institution. It establishes a collaborative partnership, allowing Gentling to obtain certain rights to commercialize technologies developed by the university's researchers. The Alabama Collateral License Agreement serves as a legal framework for the transfer and utilization of intellectual property, ensuring both parties' interests and protecting valuable inventions. It specifies the type of technologies covered by the agreement, which may include patents, copyrights, trade secrets, and trademarks. Keyword: Gentling, Inc., The University of North Texas Health Science Center Moreover, the agreement outlines the financial aspects of the collaboration, such as the payment of royalties or licensing fees from Gentling to the university in exchange for the usage of their intellectual property. Additionally, it may detail the reporting and auditing requirements, ensuring transparency and accountability throughout the agreement's duration. Different types of Alabama Collateral License Agreements may exist between Gentling, Inc. and The University of North Texas Health Science Center, depending on the specific technologies or inventions covered. Some possible types could include agreements related to biomedical research, healthcare innovations, pharmaceutical discoveries, genetic engineering, or any other field of scientific research undertaken by the university that has commercial potential. In conclusion, the Alabama Collateral License Agreement between Gentling, Inc. and The University of North Texas Health Science Center is a vital document establishing the terms under which Gentling can access and utilize the university's intellectual property. This agreement fosters a mutually beneficial relationship, allowing for the commercialization of innovative technologies while safeguarding the interests of both parties.

The Alabama Collateral License Agreement between Gentling, Inc. and The University of North Texas Health Science Center is a comprehensive legal agreement outlining the terms and conditions governing the use and licensing of intellectual property rights associated with a specific technology or invention. Keyword: Alabama Collateral License Agreement This agreement serves as a binding contract between Gentling, Inc., a cutting-edge biotechnology company, and The University of North Texas Health Science Center, a renowned academic institution. It establishes a collaborative partnership, allowing Gentling to obtain certain rights to commercialize technologies developed by the university's researchers. The Alabama Collateral License Agreement serves as a legal framework for the transfer and utilization of intellectual property, ensuring both parties' interests and protecting valuable inventions. It specifies the type of technologies covered by the agreement, which may include patents, copyrights, trade secrets, and trademarks. Keyword: Gentling, Inc., The University of North Texas Health Science Center Moreover, the agreement outlines the financial aspects of the collaboration, such as the payment of royalties or licensing fees from Gentling to the university in exchange for the usage of their intellectual property. Additionally, it may detail the reporting and auditing requirements, ensuring transparency and accountability throughout the agreement's duration. Different types of Alabama Collateral License Agreements may exist between Gentling, Inc. and The University of North Texas Health Science Center, depending on the specific technologies or inventions covered. Some possible types could include agreements related to biomedical research, healthcare innovations, pharmaceutical discoveries, genetic engineering, or any other field of scientific research undertaken by the university that has commercial potential. In conclusion, the Alabama Collateral License Agreement between Gentling, Inc. and The University of North Texas Health Science Center is a vital document establishing the terms under which Gentling can access and utilize the university's intellectual property. This agreement fosters a mutually beneficial relationship, allowing for the commercialization of innovative technologies while safeguarding the interests of both parties.